September 3, 2008 - US Oncology Inc. launched Innovent Oncology, a service division that offers a first-time opportunity for oncologists and health plans to work together through integrated programs designed specifically for the complexity of cancer care.

With a focus on supporting the entire patient cancer care continuum, Innovent Oncology reportedly offers payers and oncologists solutions that combine evidence-based treatment guidelines, patient support services and advance care planning to improve clinical outcomes while addressing costs.
The need to contain cancer costs while continuing to advance clinical science and care is growing more urgent every year. Cancer treatment costs are expected to exceed $100 billion by 2010 with absenteeism, lost productivity and other costs expected to exceed $300 billion in that same year. Every year 1.5 million people in the U.S. are diagnosed with cancer. Each of the 300 different cancer types requires its own approach to diagnosis and treatment, while a host of emerging therapies are creating even more treatment options. The associated costs are nearing a breaking point that threatens patient access to care said the company.

Innovent Oncology offers a comprehensive program addressing the primary cancer care cost drivers including: the wide variation in treatment selection, side effects that prompt ER visits and hospitalizations and ineffective interventions near the end of life.

The core services offered include:

-- Level I Pathways: Physician-developed, evidence-based pathways that reduce treatment variability and resulting costs while providing a platform for standardization, outcomes measurement and ongoing peer review.

-- Patient Support Services: An oncology-specific disease management program that increases treatment compliance, helps patients monitor and manage side effects and reduces unnecessary ER visits and hospitalizations.

-- Advance Care Planning: Transition care planning and implementation that prepares patients early in their care process for potential end-of-life issues by addressing clinical, social, financial and spiritual needs.

For more information: www.usoncology.com, www.innoventoncology.com


Related Content

News | Artificial Intelligence

July 11, 2024 — Artificial Intelligence (AI) tools can play a key role in medical imaging if radiologists trust in their ...

Time July 11, 2024
arrow
News | Radiation Therapy

June 19, 2024 — RaySearch Laboratories AB announced a milestone in radiotherapy technology where RaySearch’s RayStation ...

Time June 19, 2024
arrow
Feature | Radiology Business | By Melinda Taschetta-Millane

As we flip the page to a new month on our calendars, here is a look at the Top 10 pieces of content viewers were reading ...

Time June 04, 2024
arrow
News | Radiation Therapy

May 1, 2024 — Sun Nuclear, a Mirion Medical company, today announced the upcoming version 5.0 release of its SunCHECK ...

Time May 01, 2024
arrow
News | Artificial Intelligence

December 5, 2023 — Pixyl has announced FDA 510(k) clearance for Pixyl.Neuro, the next-generation AI software for brain ...

Time December 05, 2023
arrow
News | Artificial Intelligence

September 7, 2023 — Paige, a provider of end-to-end digital pathology solutions and clinical AI, has announced a ...

Time September 07, 2023
arrow
News | Radiology Business

July 27, 2023 — Privately-held biotech company TAE Life Sciences has announced that its board of directors has appointed ...

Time July 27, 2023
arrow
News | Proton Therapy

July 5, 2023 — RaySearch Laboratories AB announced a strategic collaboration agreement with B dot Medical Inc. aimed at ...

Time July 05, 2023
arrow
News | Radiation Therapy

May 30, 2023 — The first treatment, for a patient with prostate cancer, was successfully carried out on April 28. Yonsei ...

Time May 30, 2023
arrow
News | Oncology Information Management Systems (OIMS)

May 24, 2023 — RaySearch Laboratories AB announced that the oncology information system RayCare* (* subject to ...

Time May 24, 2023
arrow
Subscribe Now